Opioid-related adverse drug events in surgical patients: risk factors and association with clinical outcomes

References

• Viscusi ER, Pappagallo M. A review of opioids for in-hospital pain management. Hospital Practice. 2012;40(1):149–159.
   PubMedGoogle Scholar
• Sheikh A, Dhingra-Kumar N, Kelley E, et al. The third global patient safety challenge: tackling medication-related harm. Bull World Health Organ. 2017;95(8):546.
   PubMed Web of Science ®Google Scholar
• Els C, Jackson TD, Kunyk D, et al. Adverse events associated with medium‐and long‐term use of opioids for chronic non‐cancer pain: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017; (10):CD012509.
   PubMed Web of Science ®Google Scholar
• Eckstrand JA, Habib AS, Williamson A, et al. Computerized surveillance of opioid-related adverse drug events in perioperative care: a cross-sectional study. Patient Saf Surg. 2009;3(1):1–7.
   PubMedGoogle Scholar
• Kessler ER, Shah M, Gruschkus KS, et al. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy. 2013;33(4):383–391.
   PubMed Web of Science ®Google Scholar
• Minkowitz HS, Gruschkus SK, Shah M, et al. Adverse drug events among patients receiving postsurgical opioids in a large health system: risk factors and outcomes. American Journal of Health-System Pharmacy. 2014;71(18):1556–1565.
   PubMed Web of Science ®Google Scholar
• Shafi S, Collinsworth AW, Copeland LA, et al. Association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients in a large integrated health care delivery system. JAMA Surgery. 2018;153(8):757–763.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Guideline for prescribing opioids for chronic pain. J Pain Palliat Care Pharmacother. 2016;30(2):138–140.
   PubMedGoogle Scholar
• Herzig SJ, Mosher HJ, Calcaterra SL, et al. Improving the safety of opioid use for acute noncancer pain in hospitalized adults a consensus statement from the society of hospital medicine. J Hosp Med. 13(4): 263. 2018.
   PubMed Web of Science ®Google Scholar
• Homsi J, Brovman EY, Rao N, et al. The association between potential opioid-related adverse drug events and outcomes in colorectal surgery. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2019;29(11):1436–1445.
   PubMed Web of Science ®Google Scholar
• Jones MR, Brovman EY, Novitch MB, et al. Potential opioid-related adverse events following spine surgery in elderly patients. Clin Neurol Neurosurg. 2019;186:105550.
   PubMed Web of Science ®Google Scholar
• Jones MR, Kramer ME, Beutler SS, et al. The association between potential opioid-related adverse drug events and outcomes in total knee arthroplasty: a retrospective study. Adv Ther. 2020;37(1):200–212.
   PubMed Web of Science ®Google Scholar
• Baker J, Brovman EY, Rao N, et al. Potential opioid-related adverse drug events are associated with decreased revenue in hip replacement surgery in the older population. Geriatric Orthopaedic Surgery & Rehabilitation. 2020;11:2151459320915328.
   Web of Science ®Google Scholar
• Oderda GM, Senagore AJ, Morland K, et al. Opioid-related respiratory and gastrointestinal adverse events in patients with acute postoperative pain: prevalence, predictors, and burden. J Pain Palliat Care Pharmacother. 2019;33(3–4):82–97.
   PubMed Web of Science ®Google Scholar
• Herzig SJ, Stefan MS, Pekow PS, et al. Risk factors for severe opioid-related adverse events in a national cohort of medical hospitalizations. J Gen Intern Med. 2020;35(2):538–545.
   PubMed Web of Science ®Google Scholar
• Pawasauskas J, Stevens B, Youssef R, et al. Predictors of naloxone use for respiratory depression and oversedation in hospitalized adults. Am J Health Syst Pharm. 2014;71(9):746–750.
   PubMed Web of Science ®Google Scholar
• Weingarten TN, Herasevich V, McGlinch MC, et al. Predictors of delayed postoperative respiratory depression assessed from naloxone administration. Anesth Analg. 2015;121(2):422.
   PubMed Web of Science ®Google Scholar
• Yiu CH, Vitharana N, Gnjidic D, et al. Patient risk factors for opioid-related adverse drug events in hospitalized patients: a systematic review. Pharmacotherapy. 2022;42(3)194–215. .10.1002/phar.2666.
   PubMed Web of Science ®Google Scholar
• Pauly NJ, Delcher C, Slavova S, et al. Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016. J Manag Care Spec Pharm. 2020;26(3):246–252.
   PubMed Web of Science ®Google Scholar
• Rahman A, Kane J, Montastruc F, et al. Trends in new prescription of gabapentinoids and of coprescription with opioids in the 4 nations of the UK, 1993–2017. Br J Clin Pharmacol. 2021;87(8):3349–3353.
   PubMed Web of Science ®Google Scholar
• Molero Y, Larsson H, D’Onofrio BM, et al. Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden. BMJ 2019;365. 10.1136/bmj.l2147.
   PubMedGoogle Scholar
• Nielsen S, Degenhardt L, Hoban B, et al. Comparing opioids: a guide to estimating oral morphine equivalents (OME) in research. Sydney, NSW: National Drug and Alcohol Research Centre, University of NSW; 2014.
   Google Scholar
• Therapeutic Goods Administration (TGA). Clinician information sheet on opioid analgesic tapering 2020. [cited 2020 Oct 15]. Available from: https://www.tga.gov.au/sites/default/files/clinician_information_sheet_on_opioid_analgesic_tapering.pdf
   Google Scholar
• Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118(1):85–113.
   PubMed Web of Science ®Google Scholar
• Holland TJ, Penm J, Johnson J, et al. Stakeholders’ Perceptions of Factors Influencing the Use of Take-Home-Naloxone. Pharmacy. 2020;8(4):232.
   Web of Science ®Google Scholar
• Holland TJ, Penm J, Dinh M, et al. Emergency department physicians’ and pharmacists’ perspectives on take-home naloxone. Drug Alcohol Rev. 2019;38(2):169–176.
   PubMed Web of Science ®Google Scholar
• Penm J, MacKinnon NJ, Lyons MS, et al. Combatting opioid overdoses in Ohio: emergency department physicians’ prescribing patterns and perceptions of naloxone. J Gen Intern Med. 2018;33(5):608–609.
   PubMed Web of Science ®Google Scholar
• Independent Hospital Pricing Authority (IHPA). National Hospital Cost Data Collection Report, Public Sector, Round 22 2020.
   Google Scholar
• Schweizer ML, Braun BI, Milstone AM. Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship—Quasi-Experimental Designs. Infect Control Hosp Epidemiol. 2016;37(10):1135.
   PubMed Web of Science ®Google Scholar
• O’malley KJ, Cook KF, Price MD, et al. Measuring diagnoses: ICD code accuracy. Health Serv Res. 2005;40(5p2):1620–1639.
   PubMedGoogle Scholar
• Daly S, Nguyen TQ, Gabbe BJ, et al. Agreement between medical record and administrative coding of common comorbidities in orthopaedic trauma patients. Injury. 2019;50(7):1277–1283.
   PubMed Web of Science ®Google Scholar